What is UNH's Intrinsic value?

UnitedHealth Group Inc (UNH) Intrinsic Value Analysis

Executive Summary

As of April 12, 2026, UnitedHealth Group Inc's estimated intrinsic value ranges from $244.17 to $262.68 per share, depending on the valuation methodology applied.

Valuation Method Fair Value (USD) Implied Upside/Downside
Dividend Discount Model (Multi-Stage) $262.68 -13.7%
Dividend Discount Model (Stable) $244.17 -19.8%

Is UnitedHealth Group Inc (UNH) undervalued or overvalued?

With the current market price at $304.33, the stock appears to be moderately overvalued.

Understanding Intrinsic Value

Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate UnitedHealth Group Inc's intrinsic value, including:

  1. Dividend Discount Model (DDM): Values the company based on expected future dividend payments

Weighted Average Cost of Capital (WACC)

The cost of capital is a critical factor in valuation models, representing the required return for investors.

WACC Component Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.85 0.93
Cost of equity 7.8% 10.0%
Cost of debt 5.0% 5.0%
Tax rate 20.5% 21.0%
Debt/Equity ratio 0.31 0.31
After-tax WACC 6.9% 8.6%

Valuation Methods

2. Dividend Discount Model (DDM)

The DDM values a company based on its expected future dividend payments. We used two approaches:

Multi-Stage DDM:

  • Current payout ratio: 65.7%
  • Stable payout ratio: 90.0%
  • Growth transition: 5 years
  • Cost of equity: 8.9%
  • Long-term growth rate: 3.5%
  • Fair value: $262.68 (-13.7% from current price)

Stable DDM:

  • Stable payout ratio: 70% (Low) to 90% (High)
  • Cost of equity: 10.0% (Low) to 7.8% (High)
  • Long-term growth rate: 2.5% (Low) to 4.5% (High)
  • Fair value range: $123 to $365
  • Selected fair value: $244.17 (-19.8% from current price)

Key Financial Metrics

Metric Value
Market Capitalization $276234M
Enterprise Value $326502M
Trailing P/E 22.91
Forward P/E 20.89
Trailing EV/EBITDA 0.00
Current Dividend Yield 314.55%
Dividend Growth Rate (5Y) 10.65%
Debt-to-Equity Ratio 0.31

Investment Decision Framework

To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:

  1. Forecast Certainty: DCF methods rely on long-term projections, while earnings power value focuses on current normalized earnings
  2. Business Model Alignment: Dividend models are more appropriate for mature companies with established dividend policies
  3. Historical Accuracy: How well each method has predicted fair value historically

Valuation Weight Matrix

Valuation Method Weight Weighted Value
Dividend Discount Model (Multi-Stage) 57% $52.54
Dividend Discount Model (Stable) 43% $36.63
Weighted Average 100% $254.75

Investment Conclusion

Based on our comprehensive valuation analysis, UnitedHealth Group Inc's intrinsic value is $254.75, which is approximately 16.3% below the current market price of $304.33.

Key investment considerations:

  • Historical dividend growth of 10.65%

Given these factors, we believe UnitedHealth Group Inc is currently moderately overvalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.